Group One Trading
ETON icon

Group One Trading’s Eton Pharmaceutcials ETON Stock Holding History

Group One Trading’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,000
Closed -$222K – 7838
2026
Q1 		$222K Buy
9,000
+8,900
+8,900% +$156K ﹤0.01% 4029
2025
Q4 		$1.69K Sell
100
-1,500
-94% -$26.4K ﹤0.01% 7601
2025
Q3 		$34.8K Sell
1,600
-36,500
-96% -$606K ﹤0.01% 6249
2025
Q2 		$543K Buy
38,100
+35,400
+1,311% +$560K ﹤0.01% 3329
2025
Q1 		$35K Sell
2,700
-3,800
-58% -$57.4K ﹤0.01% 5437
2024
Q4 		$86.6K Buy
6,500
+3,200
+97% +$32.5K ﹤0.01% 4629
2024
Q3 		$19.8K Buy
3,300
+2,100
+175% +$8.88K ﹤0.01% 5240
2024
Q2 		$3.95K Sell
1,200
-13,900
-92% -$48.6K ﹤0.01% 6049
2024
Q1 		$56.6K Sell
15,100
-1,400
-8% -$6.11K ﹤0.01% 4613
2023
Q4 		$72.3K Sell
16,500
-4,500
-21% -$18K ﹤0.01% 4752
2023
Q3 		$87.6K Buy
21,000
+800
+4% +$3.09K ﹤0.01% 4576
2023
Q2 		$70.5K Buy
20,200
+7,100
+54% +$26.1K ﹤0.01% 4962
2023
Q1 		$50.4K Sell
13,100
-11,300
-46% -$41.2K ﹤0.01% 4839
2022
Q4 		$68.3K Sell
24,400
-2,500
-9% -$6.72K ﹤0.01% 4767
2022
Q3 		$56K Sell
26,900
-74,000
-73% -$184K ﹤0.01% 5306
2022
Q2 		$264K Sell
100,900
-26,000
-20% -$87.2K ﹤0.01% 4027
2022
Q1 		$553K Buy
126,900
+109,400
+625% +$430K ﹤0.01% 3701
2021
Q4 		$75K Buy
17,500
+2,900
+20% +$13.9K ﹤0.01% 5983
2021
Q3 		$74K Buy
14,600
+11,200
+329% +$58.3K ﹤0.01% 6206
2021
Q2 		$21K Buy
+3,400
New +$25.2K ﹤0.01% 7148

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Group One Trading's ETON Position: Q2 2026 in Review

Group One Trading opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 155 shares worth $5.61K. The stake represents ﹤0.01% of the portfolio and ranks #6684 among its holdings. This is a return to the name: Group One Trading previously reported a position in ETON as recently as Q4 2025.

Group One Trading first reported a position in ETON in Q3 2021 and has held it in 10 quarters since. The position peaked at $166K in Q4 2021. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Group One Trading held 155 shares of Eton Pharmaceutcials worth $5.61K as of Q2 2026.
  • Eton Pharmaceutcials was a new Group One Trading position in Q2 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6684 holding.
  • Group One Trading first reported a position in Eton Pharmaceutcials in Q3 2021 and has held it in 10 quarters since.
  • Group One Trading's Eton Pharmaceutcials position peaked at $166K in Q4 2021.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.